What We're Reading: Page 168
Industry reads hand-picked by our editors
Dec 02, 2020
-
Politico
Trump to FDA: Why is Europe beating us on vaccine?
-
The Wall Street Journal
Nasdaq Seeks Board-Diversity Rule That Most Listed Firms Don’t Meet
-
Reuters
AstraZeneca partner sticks with two full dose regimen in COVID trials in India
-
Bloomberg
Moderna Falls After Merck Sells Stake in the Vaccine Maker
Dec 01, 2020
Nov 30, 2020
-
STAT
The race to deliver CAR-T cancer therapy during the pandemic
-
Bloomberg
Astra Eyes Extra Global Vaccine Trial as Questions Mount
-
The New York Times
McKinsey Proposed Paying Pharmacy Companies Rebates for OxyContin Overdoses
-
Endpoints News
Kinaset launches with $40M and a JAK inhibitor from Vectura's old pipeline
Nov 25, 2020
-
Bloomberg
Astra Vaccine's 90% Efficacy in Covid Came in Younger Group
-
Associated Press
OxyContin maker Purdue Pharma pleads guilty in criminal case
-
Reuters
U.S loans $1.1 billion to Ginkgo Bioworks for pandemic effort
-
Politico
Biden eyes New Mexico governor, Obama surgeon general for health secretary
Nov 24, 2020
-
The Wall Street Journal
The Advice That Gave a Biotech Exec a Shot in the Arm
-
Reuters
Dosing error turns into lucky punch for AstraZeneca and Oxford
-
Bloomberg
Novartis Plans $2.5 Billion Share Buyback as Pipeline Grows
-
The Wall Street Journal
Russia Looks to Undercut Rivals With Cut-Price Covid-19 Vaccine
Nov 23, 2020
-
The New York Times
Politics, Science and the Remarkable Race for a Coronavirus Vaccine
-
STAT
VC raises $800M for company aiming to transform biotech manufacturing
-
San Francisco Business Times
Peninsula company wins first FDA OK for aging disease progeria
-
Endpoints News
George Church backs a startup solution to the massive gene therapy manufacturing bottleneck
Previous
